Key result
Inflammatory bowel disease and associated proatherogenic cytokines are linked to increased risk of CAD and AMI.
Answers are grounded in this paper and cite their sources.
Extraintestinal disease manifestations of inflammatory bowel disease (IBD), such as arthritis and uveitis, have been well described in the medical literature. However, there has been growing evidence suggesting an association between IBD and both coronary artery disease (CAD) and acute myocardial infarctions (AMI). In this critical review, the pathogenesis of proatherogenic inflammatory markers (CD40-CD40L, IL-6, and TNF-α) are summarised along with clinical evidence that supports the association of these makers with CAD. Moreover, clinical data are examined that suggest an increased risk of AMI and CAD in IBD patients along with recent analyses of in-hospital and post-MI outcomes of AMI in IBD patients. This comprehensive review summarises and expands upon our understanding of the growing association between both CAD and AMI in IBD patients that potentially identifies IBD as a risk factor for developing CAD.
No takes yet. Share an insight, caveat, or question.
Masood et al. (2021) conducted a review in Inflammatory bowel disease and coronary artery disease. Inflammatory bowel disease was evaluated on Coronary artery disease and acute myocardial infarction. Inflammatory bowel disease and associated proatherogenic inflammatory markers (CD40-CD40L, IL-6, TNF-α) are linked to an increased risk of coronary artery disease and acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: